📰 Roivant Sciences News
Page 4 - Roivant Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Roivant Sciences. Real-time updates on events, politics, business and more.
April 3, 2024
Roivant's shares gained 4% in afternoon trading, while its subsidiary Arbutus rose more than 17%. In a so-called "claim construction order", U.S. District Judge Mitchell Goldberg interpreted parts of the patents in ways that strengthened Arbutus' case, rejecting Moderna's proposed definitions. The order is relevant in determining whether Moderna's vaccines are covered by Arbutus' patented technology.
April 2, 2024
Roivant Sciences said on Tuesday its experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study. In the study testing...
April 2, 2024
Roivant Sciences' experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm's...
March 29, 2024
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $10.08, but opened at $10.72. Roivant Sciences shares last traded at $10.75, with a volume of 4,818,374 shares changing hands. Analysts Set New Price Targets A number of equities research analysts have recently […]
March 28, 2024
Truist Financial reiterated their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research report released on Monday, Benzinga reports. Truist Financial currently has a $23.00 price objective on the stock. A number of other research analysts have also recently issued reports on ROIV. TheStreet raised shares of Roivant Sciences from […]
March 27, 2024
Real-time index price for TSX Real Estate Capped Index (TTRE), along with buy or sell indicators, analysis, charts, historical performance, news and more
March 27, 2024
S&P Dow Jones Indices announced late Tuesday that Sunrun will replace PGT Innovations in the S&P SmallCap 600, effective prior to the market open on April 1.
March 26, 2024
NEW YORK, March 26, 2024 /PRNewswire/ -- Roivant Sciences Ltd will replace Sunrun Inc. in the S&P MidCap 400, and Sunrun will replace PGT Innovations Inc. in the S&P SmallCap 600 effective prior...
March 26, 2024
/PRNewswire/ -- Roivant Sciences Ltd (NASD:ROIV) will replace Sunrun Inc. (NASD:RUN) in the S&P MidCap 400, and Sunrun will replace PGT Innovations Inc....